The NOP receptor, (also known as ORL1, N/OFQ receptor), is a member of the opioid family of G-protein-coupled receptors that also includes κ, δ and μ receptors. The human gene encoding the NOP receptor has been localized to chromosome 20 (20q13.33).
Agonists |
Cat. No. | Product Name / Activity |
---|---|
2808 | Buprenorphine hydrochloride |
NOP agonist; also displays mixed action δ, κ and μ receptors | |
3763 | MCOPPB trihydrochloride |
Potent NOP receptor agonist | |
1780 | NNC 63-0532 |
Potent non-peptide NOP agonist; brain penetrant | |
0910 | Nociceptin |
Endogenous NOP agonist | |
1590 | [Arg14,Lys15]Nociceptin |
Highly potent and selective NOP agonist | |
1566 | [(pF)Phe4]Nociceptin(1-13)NH2 |
Potent, selective nociceptin receptor agonist | |
1092 | [Phe1Ψ(CH2-NH)Gly2]Nociceptin(1-13)NH2 |
Selective nociceptin receptor agonist | |
3932 | Orphanin FQ (1-11) |
Potent NOP agonist; displays analgesic properties | |
1387 | Ac-RYYRWK-NH2 |
Potent, selective NOP partial agonist peptide | |
3240 | SCH 221510 |
Potent and selective NOP agonist | |
Antagonists |
Cat. No. | Product Name / Activity |
2598 | (±)-J 113397 |
Potent and selective NOP antagonist | |
2481 | JTC 801 |
Selective NOP antagonist | |
1308 | [Nphe1]Nociceptin(1-13)NH2 |
Selective, competitive nociceptin antagonist | |
1118 | Nocistatin (bovine) |
Opposes action of nociceptin | |
1198 | Nocistatin (human) |
Human putative counterpart of nocistatin | |
3573 | SB 612111 hydrochloride |
Selective NOP antagonist | |
2508 | Trap 101 |
Potent and selective NOP antagonist; active in vivo | |
1552 | UFP-101 |
Potent, selective silent antagonist for NOP | |
Ligands |
Cat. No. | Product Name / Activity |
1239 | Ac-RYYRIK-NH2 |
High affinity NOP ligand | |
Other |
Cat. No. | Product Name / Activity |
1266 | Nociceptin (1-7) |
Bioactive metabolite of nociceptin | |
1119 | NocII |
Orphan neuropeptide |
The NOP receptor, (also known as ORL1, N/OFQ receptor), is a member of the opioid family of G-protein-coupled receptors that also includes κ, δ and μ receptors. NOP receptor mRNA is found in high levels in the cortex, anterior olfactory nucleus, lateral septum, hypothalamus, hippocampus, amygdala, central grey, pontine nuclei, interpeduncular nucleus, substantia nigra, raphe complex, locus coeruleus and spinal cord.
The pattern of NOP receptor distribution suggests the involvement of the NOP receptor in motor and balance control, reinforcement and reward, nociception, the stress response, sexual behavior, aggression and autonomic control of physiological processes. The human gene encoding the NOP receptor has been localized to chromosome 20 (20q13.33).
Tocris offers the following scientific literature for NOP Receptors to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Written by Sonia Tucci, Lynsay Kobelis and Tim Kirkham, this review provides a synopsis of the increasing number of peptides that have been implicated in appetite regulation and energy homeostasis; putative roles of the major peptides are outlined and compounds available from Tocris are listed.
Peripheral sensitization is the reduction in the threshold of excitability of sensory neurons that results in an augmented response to a given external stimulus. This poster outlines the excitatory and inhibitory signaling pathways involved in modulation of peripheral sensitization. The role of ion channels, GPCRs, neurotrophins, and cytokines in sensory neurons are also described.